Company overview
Zymo Research provides nucleic acid purification kits, next-generation sequencing services, and automation solutions for epigenetics, microbiomics, and NGS workflows. Their portfolio includes high-throughput DNA/RNA extraction, plasmid purification, methylation analysis, and the MultiOmiX Workstation for automated microbiome processing. Products and services support academic and biopharmaceutical research with reliable, cost-effective tools.
ZYMO RESEARCH is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include zymo research, epigenetics kits, microbiomics, ngs services, dna purification, ngs library prep.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.zymoresearch.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- zymo research, epigenetics kits, microbiomics, ngs services, dna purification, ngs library prep
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What are Zymo Research's main product categories for pharma R&D?
- Key offerings include epigenetics kits for DNA methylation analysis, microbiomics solutions for DNA/RNA purification and NGS library prep, high-throughput automated DNA extraction, and plasmid purification systems.
- Does Zymo Research offer NGS services and automation?
- Yes, they provide end-to-end NGS analysis services with bioinformatics, plus the MultiOmiX Workstation for fully automated high-throughput microbiome workflows processing up to 96 samples per run.
- What industries and applications does Zymo Research serve?
- They serve academia, biopharmaceutical research, and diagnostics in epigenetics, next-gen sequencing, and microbiome analysis, with global facilities and a focus on reproducible, scalable solutions.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
